GIONCO DAVID (Chief Accounting Officer) sold 3.9% of their position (11.52K shares) of STEMLINE THERAPEUTICS INC on the open market
Open‑market sale worth $55.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/3/2020ACC: 0001104659-20-043324
Officer· Chief Accounting Officer
Since Feb 2019
-11.52K
Net shares
Net seller
$55.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.52K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.52K
Price / share
$4.79
Trade value
$55.20K
% of position
3.9%
4/1/2020
294.40K→282.88K
Total
Net shares
−11.52K
Net value
-$55.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2020 | S · Sale | −11.52K | $4.79 | $55.20K | 3.9% | 294.40K | 282.88K |
| Total | −11.52K | -$55.20K | ||||||
Derivative Transactions0
No derivative transactions reported